Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperpolarized 129Xe MR Lung Imaging in Infants
NCT04995562Phase 4Recruiting
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- May 2020
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hyperpolarized xenon gas in respiratory distress syndrome (RDS), bronchopulmonary dysplasia (BPD), pulmonary hypertension (PH), congenital diaphragmatic hernia (CDH), congenital lung malformation (CLM), sponsored by Cincinnati Children's Hospital Medical Center. Started May 2020; status: recruiting.
02
Drugs
hyperpolarized xenon gas
03
Conditions
respiratory distress syndrome (RDS)bronchopulmonary dysplasia (BPD)pulmonary hypertension (PH)congenital diaphragmatic hernia (CDH)congenital lung malformation (CLM)
Beyond the preview
Go deeper on NCT04995562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04995562.